DKK478.70
1.40% day before yesterday
Copenhagen, Jun 06, 05:00 pm CET
ISIN
DK0060336014
Symbol
NSIS B
Industry

Novonesis Stock price

DKK478.70
+51.40 12.03% 1M
+61.80 14.82% 6M
+71.00 17.41% YTD
+58.80 14.00% 1Y
+114.30 31.37% 5Y
+156.00 48.34% 10Y
+419.20 704.54% 20Y
Copenhagen, Closing price Fri, Jun 06 2025
+6.60 1.40%
ISIN
DK0060336014
Symbol
NSIS B
Industry

Key metrics

Market capitalization DKK220.06b
Enterprise Value DKK230.83b
P/E (TTM) P/E ratio 60.52
EV/FCF (TTM) EV/FCF 43.48
EV/Sales (TTM) EV/Sales 6.30
P/S ratio (TTM) P/S ratio 6.00
P/B ratio (TTM) P/B ratio 2.66
Dividend yield 1.30%
Last dividend (FY24) DKK6.20
Revenue (TTM) Revenue DKK36.65b
EBIT (operating result TTM) EBIT DKK6.98b
Free Cash Flow (TTM) Free Cash Flow DKK5.31b
Cash position DKK1.91b
EPS (TTM) EPS DKK7.91
P/E forward 41.05
P/S forward 7.00
EV/Sales forward 7.34
Show more

Is Novonesis a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,823 stocks worldwide.

Novonesis Stock Analysis

Unlock Scores for Free

Analyst Opinions

18 Analysts have issued a Novonesis forecast:

14x Buy
78%
2x Hold
11%
2x Sell
11%

Analyst Opinions

18 Analysts have issued a Novonesis forecast:

Buy
78%
Hold
11%
Sell
11%

Financial data from Novonesis

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
36,655 36,655
-
100%
- Direct Costs 18,714 18,714
-
51%
17,941 17,941
-
49%
- Selling and Administrative Expenses 7,298 7,298
-
20%
- Research and Development Expense 3,885 3,885
-
11%
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT 6,976 6,976
-
19%
Net Profit 3,671 3,671
-
10%

In millions DKK.

Don't miss a Thing! We will send you all news about Novonesis directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Novonesis A/S engages in the era of biosolutions. It innovate and develop transformative biosolutions that improve the way the world produces, consumes, and lives. The company was founded on January 29, 2024 is headquartered in Lyngby, Denmark.

Head office Denmark
CEO Ester Baiget
Website www.novozymes.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today